S. Morin

Pharmacogenetics of Acenocoumarol Pharmacodynamics

D. Tregouet, M. Loriot, P. Beaune, 2004, Clinical pharmacology and therapeutics.

Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers.

M. Loriot, C. Verstuyft, L. Becquemont, 2001, Pharmacogenetics.

Genetic and environmental risk factors for oral anticoagulant overdose

M. Loriot, C. Funck-Brentano, C. Verstuyft, 2003, European Journal of Clinical Pharmacology.

[A new, rapid and robust genotyping method for CYP2C9 and MDR1].

U. Brinkmann, M. Loriot, V. Barbu, 2003, Annales de biologie clinique.

Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations

V. Barbu, C. Verstuyft, L. Becquemont, 2003, Fundamental & clinical pharmacology.

Is diclofenac a valuable CYP2C9 probe in humans?

M. Loriot, C. Funck-Brentano, J. Poirier, 2001, European Journal of Clinical Pharmacology.